These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 1741168

  • 1. c-ets-1 DNA binding to the PEA3 motif is differentially inhibited by all the mutations found in v-ets.
    Leprince D, Crepieux P, Stehelin D.
    Oncogene; 1992 Jan; 7(1):9-17. PubMed ID: 1741168
    [Abstract] [Full Text] [Related]

  • 2. A new mechanism of oncogenic activation: E26 retroviral v-ets oncogene has inverted the C-terminal end of the transcription factor c-ets-1.
    Leprince D, Crepieux P, Laudet V, Flourens A, Stehelin D.
    Virology; 1993 Jun; 194(2):855-7. PubMed ID: 8389086
    [Abstract] [Full Text] [Related]

  • 3. Back-mutation of the V-Ets to the C-Ets carboxy-terminal amino acids in the P135gag-myb-ets results in chicken neuroretina cells transformation and loss of basic fibroblast growth factor responsiveness.
    Garrido C, Leprince D, Plaza S, Aumercier M, Stéhelin D, Saule S.
    Oncogene; 1996 Apr 04; 12(7):1449-56. PubMed ID: 8622861
    [Abstract] [Full Text] [Related]

  • 4. Localization and modulation of the DNA-binding activity of the human c-ets-1 protooncogene.
    Reddy ES, Rao VN.
    Cancer Res; 1990 Aug 15; 50(16):5013-6. PubMed ID: 2165853
    [Abstract] [Full Text] [Related]

  • 5. A model for gene evolution of the ets-1/ets-2 transcription factors based on structural and functional homologies.
    Albagli O, Soudant N, Ferreira E, Dhordain P, Dewitte F, Begue A, Flourens A, Stehelin D, Leprince D.
    Oncogene; 1994 Nov 15; 9(11):3259-71. PubMed ID: 7936650
    [Abstract] [Full Text] [Related]

  • 6. Phylogeny of the p68c-ets-1 amino-terminal transactivating domain reveals some highly conserved structural features.
    Albagli O, Flourens A, Crepieux P, Begue A, Stehelin D, Leprince D.
    Oncogene; 1992 Jul 15; 7(7):1435-9. PubMed ID: 1620554
    [Abstract] [Full Text] [Related]

  • 7. Molecular analysis of the ets genes and their products.
    Watson DK, Ascione R, Papas TS.
    Crit Rev Oncog; 1990 Jul 15; 1(4):409-36. PubMed ID: 1964597
    [Abstract] [Full Text] [Related]

  • 8. A residue of the ETS domain mutated in the v-ets oncogene is essential for the DNA-binding and transactivating properties of the ETS-1 and ETS-2 proteins.
    Soudant N, Albagli O, Dhordain P, Flourens A, Stéhelin D, Leprince D.
    Nucleic Acids Res; 1994 Sep 25; 22(19):3871-9. PubMed ID: 7937106
    [Abstract] [Full Text] [Related]

  • 9. Ets oncogene family.
    Dhulipal PD.
    Indian J Exp Biol; 1997 Apr 25; 35(4):315-22. PubMed ID: 9315229
    [Abstract] [Full Text] [Related]

  • 10. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
    Watson DK, Robinson L, Hodge DR, Kola I, Papas TS, Seth A.
    Oncogene; 1997 Jan 16; 14(2):213-21. PubMed ID: 9010223
    [Abstract] [Full Text] [Related]

  • 11. The oncoprotein v-Ets is less selective in DNA binding than c-Ets-1 due to the C-terminal sequence change.
    Hahn SL, Wasylyk B.
    Oncogene; 1994 Sep 16; 9(9):2499-512. PubMed ID: 8058313
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The chicken cellular progenitor of the v-ets oncogene, p68c-ets-1, is a nuclear DNA-binding protein not expressed in lymphoid cells of the spleen.
    Leprince D, Gesquiere JC, Stehelin D.
    Oncogene Res; 1990 Sep 16; 5(4):255-65. PubMed ID: 2204018
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Myb and Ets related transcription factors are required for activity of the human lck type I promoter.
    McCracken S, Leung S, Bosselut R, Ghysdael J, Miyamoto NG.
    Oncogene; 1994 Dec 16; 9(12):3609-15. PubMed ID: 7970721
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sequence specific binding of Ets-1 to the mouse cytokeratin EndoA gene enhancer.
    Hamazato F, Fujimura Y, Tamai Y, Takemoto Y, Matsushiro A, Nozaki M.
    Biochem Biophys Res Commun; 1993 Apr 30; 192(2):430-8. PubMed ID: 7683460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.